Working… Menu

An International Study to Evaluate Diagnostic Efficacy of Flurpiridaz (18F) Injection PET MPI in the Detection of Coronary Artery Disease (CAD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03354273
Recruitment Status : Recruiting
First Posted : November 27, 2017
Last Update Posted : December 22, 2020
Pharmaceutical Product Development, LLC
Information provided by (Responsible Party):
GE Healthcare